Medela Inc Earns Accreditation Status 

       Medela Inc (McHenry, Ill) was awarded accreditation status by the Accreditation Commission for Health Care Inc (ACHC). ACHC, a private, nonprofit corporation that is certified to ISO 9001:2000 standards, was developed by home care and community-based providers to help companies improve business operations and quality of patient care. Medela chose to work with ACHC specifically because of its experience in developing the highest quality standards for suppliers of home health medical equipment.
       Visit http://www.medela.com for more information.

Collaboration Results in Development of Novel Wound Care Product

       Innocoll Technologies Ltd (Ashburn,Va) has entered into a strategic collaboration with TGR BioSciences Pty Ltd (Adelaide, South Australia) to evaluate the combination of Innocoll’s collagen-based drug delivery technology, CollaRx^™, with TGR Biosciences proprietary wound healing compound,TGR-265. Innocoll’s CollaRx technology platform is a biocompatible and fully bioresorbable collagen matrix for localized drug delivery.
       Comprised of purified type I fibrillar collagen, it can be prepared in the form of a lyophilized sponge or film-cast membrane using a proprietary manufacturing process. Both CollaRx formats can be surgically implanted or applied topically to wounds, enabling drugs to be delivered locally to the intended site of action—minimizing any systemic- related side effects.
       TGR-265 is a naturally-derived bioactive protein that has been show through extensive in-vitro and in-vivo pre-clinical testing to stimulate the fibrogenic response during the production of host type I collagen and deposition of intracellular matrix.
       Visit http://www.innocoll-tech.com for more information.

KCI's Pressure Ulcer Prevention Program Emphasizes Prevention

       Kinetic Concepts Inc (San Antonio,Tex) has developed a new program designed to help hospitals comply with new Medicare rules that emphasize pressure ulcer prevention.
       The Centers for Medicare and Medicaid Services (CMS) announced that the treatment of hospital-acquired pressure ulcers and/or bedsores would no longer be reimbursed.
       The company’s program addresses prevalence and incidence—2 key measurements of wound care treatment protocols. Program components include patient assessment, documentation, and online educational programs to increase awareness and compliance, as well as optimize patient care and enhance reimbursement.
       Visit http://www.kci1.com for more information.